US demand for infection prevention products and services will increase 4.8 percent annually through 2013. The best growth opportunities are anticipated in safety-enhanced devices that reduce the risk of health care acquired infections. Medical waste disposal and sterilization supplies, as well as high level disinfectants, will also do well.
This study analyzes the $18.6 billion US infection prevention industry. It presents historical demand data for the years 1998, 2003 and 2008, and forecasts for 2013 and 2018 by product (e.g., protective apparel and textiles, safety-enhanced devices, disinfectants, sterilization supplies and equipment, medical waste disposal supplies), service (medical waste disposal, contract sterilization) and market.
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 22 industry players, including 3M, CareFusion and Becton Dickinson.
Additional Information
Life science, health care markets to see strong gains
Advances in biotechnology are boosting opportunities for infection prevention products and services in life science markets. Stringent safety and containment standards related to the handling and processing of genetically modified microorganisms and other biologicals are spurring demand for products in medical laboratories. The persisting threat of bioterrorism is also creating an emerging infection prevention market in the area of homeland security. Revenues for infection prevention products and services are also benefitting from expanding applications in the manufacturing and quality assurance of pharmaceuticals and medical devices. Although projected for expanded usage in health care and life science sectors, most infection prevention consumables and disposables will continue to lack pricing flexibility due to multiple supplier competition and limited opportunities for product differentiation. Bid contracts with centralized purchasing departments or buying groups will remain the primary method of sales to hospitals and other large customers.
Surgical drapes and gowns, disinfectants, medical and laboratory gloves, face masks and sterilization supplies will continue to comprise the top selling groups of infection prevention consumables and disposables because of the critical nature of applications served. Revenues for contract sterilization and medical waste disposal services will also continue to expand favorably based on cost efficiency and convenience advantages offered to hospitals and medical product manufacturers. and upward trends in surgery and other direct contact medical and dental procedures. Sales of infection prevention equipment will expand at a comparatively slow pace due to the widespread availability of used, refurbished systems and decelerating growth in the number of newly constructed end-user facilities.
Study coverage
Infection Prevention Products & Services, a new Freedonia industry study, is priced at $4400. It presents historical data plus forecasts for 2011 and 2016 for supplies, equipment and services by type and market. This US study analyzes the market environment, examines trends in medical product regulation, and assesses new product development. In addition, it also evaluates company market share and profiles 23 US industry competitors.
(0 items)
